Dimitri E. Grigoriadis

Person

Carlsbad, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment of congenital adrenal hyperplasia
- Patent number 11,730,739
- Issue date Aug 22, 2023
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of congenital adrenal hyperplasia
- Patent number 11,311,544
- Issue date Apr 26, 2022
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of congenital adrenal hyperplasia
- Patent number 10,905,690
- Issue date Feb 2, 2021
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Corticotropin-releasing factor2 receptors
- Patent number 7,034,118
- Issue date Apr 25, 2006
- Neurocrine Biosciences, Inc.
- Timothy W Lovenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Corticotropin-releasing factor2 receptors
- Patent number 6,723,841
- Issue date Apr 20, 2004
- Neurocrine Biosciences Inc.
- Timothy W. Lovenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1N-alkyl-n-arylpyrimidinamines and derivatives thereof
- Patent number 6,342,503
- Issue date Jan 29, 2002
- DuPont Pharmaceuticals Company
- Paul Edward Aldrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nucleic acid encoding corticotropin-releasing factor.sub.2...
- Patent number 5,786,203
- Issue date Jul 28, 1998
- Neurocrine Biosciences, Inc.
- Timothy W. Lovenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
- Publication number 20240058342
- Publication date Feb 22, 2024
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
- Publication number 20210361659
- Publication date Nov 25, 2021
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
- Publication number 20210137926
- Publication date May 13, 2021
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Valbenazine for Treating Schizophrenia or Schizoaffective Di...
- Publication number 20210113553
- Publication date Apr 22, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Compositions Comprising an Antipsychotic Drug and a...
- Publication number 20200206215
- Publication date Jul 2, 2020
- Neurocrine Biosciences, Inc.
- Samuel Roger Jesse Hoare
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Compositions Comprising an Antipsychotic Drug and a...
- Publication number 20190381029
- Publication date Dec 19, 2019
- Neurocrine Biosciences, Inc.
- Samuel Roger Jesse Hoare
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
- Publication number 20190231781
- Publication date Aug 1, 2019
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRF1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CONGENITAL ADRENAL H...
- Publication number 20170020877
- Publication date Jan 26, 2017
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Corticotropin-releasing factor2 receptors
- Publication number 20040185533
- Publication date Sep 23, 2004
- Neurocrine Biosciences, Inc.
- Timothy W. Lovenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Corticotropin-releasing factor2 receptors
- Publication number 20020077468
- Publication date Jun 20, 2002
- Timothy W. Lovenberg
- C07 - ORGANIC CHEMISTRY

Dimitri E. Grigoriadis

Person

Patents Grantslast 30 patents

Treatment of congenital adrenal hyperplasia

Treatment of congenital adrenal hyperplasia

Treatment of congenital adrenal hyperplasia

Corticotropin-releasing factor2 receptors

Corticotropin-releasing factor2 receptors

1N-alkyl-n-arylpyrimidinamines and derivatives thereof

Isolated nucleic acid encoding corticotropin-releasing factor.sub.2...

Patents Applicationslast 30 patents

TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

Use of Valbenazine for Treating Schizophrenia or Schizoaffective Di...

Pharmaceutical Compositions Comprising an Antipsychotic Drug and a...

Pharmaceutical Compositions Comprising an Antipsychotic Drug and a...

TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

CRF1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CONGENITAL ADRENAL H...

Corticotropin-releasing factor2 receptors

Corticotropin-releasing factor2 receptors